Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tristel plc (GB:TSTL)
:TSTL
Holding GB:TSTL?
Track your performance easily
TSTL Stock Chart & Stats
Day’s Range― - ―
52-Week Range346.00p - 510.00p
Previous CloseN/A
Volume2.07K
Average Volume (3M)46.03K
Market Cap
£186.00M
Enterprise Value211.03M
Total Cash (Recent Filing)$5.09M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.5
Beta0.58
Next Earnings
Feb 24, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 28, 2024Dividend Yield3.47%
Share Statistics
EPS (TTM)0.14
Shares Outstanding47,692,093
10 Day Avg. Volume61,656
30 Day Avg. Volume46,031
Standard Deviation0.11
R-Squared0.01
Alpha0.00817
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.71
Price to Cash Flow (P/CF)17.20
P/FCF Ratio18.80
Enterprise Value/Market Cap1.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.23
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tristel News
PremiumCompany Announcements
Tristel Schedules Interim Results Briefings for February 2025
PremiumCompany Announcements
Tristel plc Announces Successful AGM Results and Incentive Plan Approvals
PremiumCompany Announcements
Tristel plc Reports Record Growth and Expands Market Influence
PremiumCompany Announcements
Tristel PLC Announces AGM and Financial Outlook
PremiumCompany Announcements
Tristel Expands Share Capital with AIM Listing
PremiumCompany Announcements
Tristel PLC Expands Share Capital with New Issuance
PremiumCompany Announcements
Tristel PLC Achieves Record Growth in 2024Options Prices
Currently, No data available
---
Ownership Overview
0.64% Insiders
0.03% Mutual Funds
― Other Institutional Investors
99.00% Public Companies and
Individual Investors
TSTL FAQ
What was Tristel plc’s price range in the past 12 months?
Tristel plc lowest share price was 346.00p and its highest was 510.00p in the past 12 months.
What is Tristel plc’s market cap?
Tristel plc’s market cap is £186.00M.
When is Tristel plc’s upcoming earnings report date?
Tristel plc’s upcoming earnings report date is Feb 24, 2025 which is in 37 days.
How were Tristel plc’s earnings last quarter?
Tristel plc released its earnings results on Oct 21, 2024. The company reported 0.072p earnings per share for the quarter, beating the consensus estimate of N/A by 0.072p.
Is Tristel plc overvalued?
According to Wall Street analysts Tristel plc’s price is currently Overvalued.
Does Tristel plc pay dividends?
Tristel plc pays a Annually dividend of 13.52p which represents an annual dividend yield of 3.47%. See more information on Tristel plc dividends here
What is Tristel plc’s EPS estimate?
Tristel plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tristel plc have?
Tristel plc has 47,692,093 shares outstanding.
What happened to Tristel plc’s price movement after its last earnings report?
Tristel plc reported an EPS of 0.072p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.899%.
Which hedge fund is a major shareholder of Tristel plc?
Currently, no hedge funds are holding shares in GB:TSTL
---
Tristel Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.17%
12-Months-Change
Fundamentals
Return on Equity
20.57%
Trailing 12-Months
Asset Growth
6.63%
Trailing 12-Months
Company Description
Tristel plc
Tristel PLC is a player in the healthcare platform. The company is a manufacturer of infection prevention and contamination control products. Its core product candidate is a chlorine dioxide formulation. Its operating segments include Hospital medical device decontamination and Hospital environmental surface disinfection. It caters to three market avenues: The Human Healthcare market, The Contamination Control market, and the Animal Healthcare market. The Human Healthcare division deals with hospital infection prevention and accounts for most of the company's revenues.
---
Technical Analysis
Advanced Medical Solutions
―
EKF Diagnostics Holdings
―
Benchmark Holdings
―
HUTCHMED (China) Limited
―
Smith & Nephew
―
RUA Life Sciences
―
---